Bipolar Ii Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Ii Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-01-21Clinical Trial Update: Long-term Potentiation Disruption Underlying Cognitive Impairment in ECT [EARLY_Phase 1]
An EARLY Phase 1 clinical trial investigating long-term potentiation disruption underlying cognitive impairment in electroconvulsive therapy…
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Bipolar Disorder
ProgenaBiome's non-interventional pilot study investigating the role of gut flora in bipolar disorder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-20Clinical Trial Update: Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old [Phase 4]
Open-label Phase 4 study of lurasidone (Latuda) for mania in youths aged 6-17 was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-06-09Clinical Trial Update: rTMS for Treatment of Depressed Phase of Bipolar Disorder Type II [Phase 2]
A Phase 2 trial evaluating repetitive transcranial magnetic stimulation for the depressed phase of bipolar II disorder was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-31Clinical Trial Update: Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence [Phase 2]
A Phase 2 open-label trial of Depakote ER in patients with bipolar I/II depression and alcohol use disorder has been withdrawn from the stud…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.